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INTRODUCTION 
       Depression is common illness worldwide. According to WHO, 300 million 
people affected globally. It became serious health condition when it is long 
lasting and with moderate to severe intensity. It causes significant impairment 
in social and occupational areas.  It is also a leading cause for suicide. It can be 
misdiagnosed often due to inaccurate assessment and various clinical 
presentations. 
 Depending upon severity, it can be classified into 3 types –  
 Mild, 
 Moderate,  
 Severe. 
 When there is presence of manic episode, diagnosis would be made as 
bipolar affective disorder. Treatment will be different if its case of bipolar 
disorder. Clinically it will be difficult as both are having overlapping 
symptoms.  
 Depressive episodes are characteristic of both major depressive disorder 
and bipolar disorder. Distinguishing between both disorders is essentially 
important because there are differences in the optimal management of these 
conditions. Anti- depressant treatment of bipolar depression can adversely 
affect long term prognosis by causing destabilization of mood and more 
frequent depressive episode and can lead to treatment resistance.1 
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 Despite decades of effort, we still lack a reliable biological marker to 
distinguish between bipolar depression and major depressive disorder. 
Misconceptions about diagnosis of these conditions are 
 Both are clear cut and separable condition 
 Easy to diagnose with careful assessment 
 No true differences found between clinical features of both. 
 Most people with bipolar disorder experience depression rather than 
mania in their first episode of illness.  
 The SANE report in Australia found that over two-thirds of people with 
bipolar disorder were misdiagnosed, most common alternative diagnosis were 
major depression (60%). It is clinically desirable to recognize, or at least 
suspect, bipolar depression at an early stage of a bipolar illness. 
 Number of studies has attempted to distinguish the phenomenology of 
depression in MDD and bipolar disorder. In bipolar depression, a greater 
prevalence of atypical features or reverse neuro-vegetative symptoms was 
reported by most studies but not all 2.  Like-wise a greater prevalence of 
melancholic symptoms among bipolar depressed patient was identified in 
several reports.   
  Finally, family history of bipolar disorder, early age of onset, shorter 
duration of individual episode, frequent episodes, irritability, anger, sub 
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threshold mixed  symptoms such as over activity and psychosis have also been 
associated with bipolar depression. 
          For planning a holistic treatment, it is important to know how these two 
conditions differ from each other. 
           In Indian setting, there are very few studies comparing Bipolar and 
Unipolar depression for phenomenology and substance use. In our study, we 
were assessed illness parameters and clinical variables and use of substance 
among two groups. 
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 Review of literature:  
                Depression is a heterogenous disorder. The term depression was 
derived from Latin word - ‘Deprimere’ which means to press down. 
                Ancient Greek physician Hippocrates recognized a syndrome of 
melancholia with mental and physical symptoms It is known as black bile. It 
comprises symptom of aversion to food, sleeplessness, irritability and 
despondency and restlessness.3 
 Later Emil Kraeplin uses the term depression an encompassing concept. 
 Globally it accounts for one-third DALY. Proportion of people with 
depression to be 4.4%. it is more common in females, with peak of around 55-
75yrs of both sexes. 
 Epidemiology in India (WHO)4 
 It accounts DALY for 37%, by 2025 it is expected to rise by 2.6 
million. As per NMHS (2015-2016) in India, 1 in 20 people over 
18 yrs of age have suffered from depression. 
 Depression is most common psychiatric disorder present in 
primary care – 63.6% 
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Unipolar depression: 
         Major depressive disorder is most common mood disorder. It can be 
single episode or recurrent episodes.  
       According to ICD – 10, Depression predominantly has low mood, loss 
of interest, and enjoyment and reduced energy associated with increased 
fatigability and reduced activity, 2 of above symptoms present for 2 weeks. 5 
Other features include  
 Reduced attention and concentration  
 Low self esteem and self-confidence 
 Ideas of guilt  
 Pessimistic views of future 
 Disturbed sleep and appetite 
 Ideas or acts of self-harm or suicide 
  They can present as mild moderate and severe. With or without somatic 
syndrome.   
 
 
 Somatic symptoms include loss of pleasure in normal activities, early 
morning awakening, psychomotor agitation or retardation, loss of appetite and 
loss of weight of around 5% or more in past month, decreased sexual function. 
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According to DSM-5, 6  
In addition to symptoms and they also mention about specifiers 
Anxious,  
Mixed, 
Melancholic, 
Atypical, 
Mood congruent psychosis, 
Mood incongruent psychosis, 
Catatonia 
Peripartum onset and  
Seasonal pattern.  
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Bipolar depression  
           Bipolar depression is common like unipolar depression but often 
misdiagnosed as they are having overlapping symptomatology. It has mixed 
depressive episode and manic or hypomanic episodes. 
         Certain symptoms are common in Bipolar depression rather than unipolar 
depression, includes increased appetite, presence of psychosis, and excessive 
sleep.7  
           These symptoms are not consistently present in all individuals. And 
also, there is significant difference in duration of symptoms8. The most 
complicated part is treatment of bipolar depression which should plan 
according to prior episodes and should decide upon starting of mood stabilizers 
rather than anti-depressants alone. Antipsychotics also useful in the treatment. 
Combination therapy is more helpful than monotherapy.9,10 
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       Bipolar 2 characerized by depressive episode with atleast one episode of 
hypomania, not necessary for full blown manic episode.13 
        The diagnosis of bipolar in clinical practice not only limited with above 
two types,because of complexity of presentation.  
 HAGOP AKISKAL14 described   bipolar spectrum  which includes 
various presentations: 
Bipolar 0.25 Unstable form of unipolar depression,respond to 
antidepressants rapidly 
Bipolar 0.5                    schizoaffective disorder/schizobipolar disorder 
Bipolar 1.5 Protracted hypomania without depression  
Bipolar 2.5 Cyclothymic patients develop major depressive 
disorder.  
Bipolar 3 Antidepressant induced manic or hypomanic 
episodes 
Bipolar 3.5 Bipolar disorder associated with Substance use  
Bipolar 4 Depressive episodes with pre existing 
hyperthymic temperament 
Bipolar 5  Depression with mixed hypomania 
Bipolar 6 Bipolar with dementia. 
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Why it is important to know?? 
 20% of Bipolar depression patients presents with depressive episode 
diagnose correctly in first year of treatment,15 it takes few years to give 
appropriate treatment from the time of onset to diagnosis16. And it is very to 
differentiate depression in bipolar depression and unipolar depression, even 
though some symptoms become more evident in one condition.17  
 More than 60% of Bipolar depression are diagnosed as Unipolar 
depression18,19. Misdiagnosis depression leads to serious consequences, that 
involve inappropriate treatment in turn lead to poor prognosis20, increase rates 
of switching to mania, increase rates of suicides and more health care costs.21,22, 
It is essential to diagnose bipolar depression in early stages to prevent 
complications.23,24 
 
Figure 2: Life chart of mood disorder 
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Why it is difficult to distinguish? 
 It is very crucial to differentiate unipolar depression from bipolar 
depression in early stages. Many studies have concluded that the presentation 
of depressive symptoms more marked than hypomania/ manic symptoms 
during the course or initial presentation of bipolar depression. Another reason 
would be presence of sub threshold symptoms of depression25 
 NIMH Collaborative Depression Study conclude that 9% people of 
bipolar disorder-I and 1% people of bipolar disorder- II, only presents with 
classical symptom of mania and hypomania26,27, but around 30-50% showed 
sub threshold symptoms.  
 The distinction between unipolar and bipolar disorder mainly in the field 
of psychopharmacology. Various clinical studies shown the misdiagnosis and 
mistreatment.28   It covers a wide range of spectrum ranging from bipolar to 
cyclothymia, hypomania, unspecified bipolar. They are also mentioned about 
limitation in categorical diagnosis.29 
 People of unipolar depression shows more of bipolar affinity. So that, 
they have proposed bipolar spectrum mentioned earlier which covers discrete 
range of syndromes.30 
 In bipolar disorder, duration was 3-6 months average, in bipolar 
Recovery period will be 2 to 3 years from index diagnosis. People with bipolar 
depression have more episodes in lifetime but no difference in severity.31 
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                    Misdiagnosis of unipolar in bipolar disorder around 40% of 
patients, and the time period for diagnosis from onset to reach mental services 
would be 7.5 years. Consequence of misdiagnosis is long duration of untreated 
illness due to inadequate treatment. Presence of residual symptoms due to 
inadequate treatment.32 
Antidepressant-Associated Mania 
 Anti depressant usage leads to increased number of episodes and 
increase frequency of episodes, so overall increase in manic episodes common. 
Bipolar depression has more cases of antidepressant induced manic episodes33. 
Prevalence of antidepressant induced mania in bipolar depression about  
20%-50%.  
 Along with that, increase number of mixed episodes commonly noticed 
in this group. Associated  mixed symptoms leads to suicide, incidence of 
suicidality is high in this group.34 
 Studies found that increased rates of switching to manic episode occurs 
with following drugs such as tricyclic antidepressants showing higher rates and 
drugs like paroxetine, bupropion, moclobemide may have low rates.35  
 Antidepressant prophylaxis leads to rapid cycling course in bipolar 
individuals and rapid cyclers presented with depression in their first episode.36  
 Rapid cycling more common among young age, women, bipolar II.37 
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Risk factors for antidepressant-induced mania:38,39,40,41 
1. Young age 
 
2. Rapid cycling 
3. Substance abuse  
4. Bipolar depression I > Bipolar depression II 
5. Mixed episodes 
6. More with tricyclic antidepressants. 
7. Action of nor-epinephrine 
Neurobiology:  
 Neurobiological abnormalities in depression involves several prefrontal 
structures and limbic structures and interconnected circuits.42 
 
Figure 3, neurobiology of depression, 
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Functional and structural changes :   
 Neuroanatomical areas which involved  
1) Ventromedial prefrontal cortex (VMPFC),  
2) Lateral orbital prefrontal cortex (LOPFC),  
3) Dorsolateral prefrontal cortex (DLPFC),  
4) Anterior cingulated cortex (ACC), 
5)  Ventral striatum (including nucleus accumbens), amygdala and the 
hippocampus. 
 The areas which mentioned above involved in each symptoms, but vary 
in individuals.43 
 Prefrontal cortex along with hippocampus, cingulate, amygdala  
regulates mood regulation, learning and memory process.44 
 Executive function is maintained by  Lateral orbito frontal cortex and 
venteromedial prefrontal cortex have a reciprocal action with dorso-lateral 
prefrontal cortex.45 
 On regional blood flow studies,  people with MDD shows hypoactivity 
in dorsolateral prefrontal cortex and hyperactivity in other 2 areas.46 
 Reduced hippocampal volume noted in depression. It is directly 
proportional to duration and number of episodes.(32,33) 
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Figure 4, neuroanatomical correlates of depression 
Molecular processes mediating neurobiological changes 
 Neuroendocrine dysregulation involves increase cortisol levels during 
stress which alter neuroplasticity, in major depressive disorder.47 This also 
cause impact over hippoacampus and amygdala. Stress also cause increase pro 
inflammatory cytokines causes disruption in neurotrophic factors and 
monoamines regulation.48 
Role of neurotransmitters:  
 Serotonin and norepinephrine are two important mono amines 
implicated in pathology of depression. Chronic treatment leads to activation 
protein kinase A, targets increased production of  Brain Derived Neurotrophic 
Factor(BDNF) via genes. The role of neurotrasmitters implicated in the 
treatment.49 
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Figure 5, neurotransmitters 
Genetics: 
            Various genes involved in the pathogenesis of depression mainly 
polymorphisms in the glucocorticoid receptor gene NR3C1, group-2 
metabotropic glutamate receptor gene (GRM3), insertion-deletion promoter 
variant (serotonin transporter-linked polymorphic region [5HTTLPR]) in the 
serotonin transporter gene (SLC6A4) genetic variants in TREK1 catechol-O-
methyltransferase (COMT) gene, corticotrophin-releasing hormone (CRH) 
receptor-1 (CRHR1) and CRH binding protein (CRHBP).50,51,52,53,54 
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Neuroimaging : 
 Structural neuroimaging:  
 A  study 55 used diffusion tensor imaging (DTI) show decreased FA left 
superior longitudinal fasciculus  in both unipolar and bipolar depression and in 
right uncinate fasciculus decreased activity in bipolar depression and in left 
inferior longitudinal fasciculus in unipolar depression.56,57,58 
 Other findings include white matter hyperintensities  occur in both when 
they are having comorbid medical condition. Decreased volume in left 
habenula seein in bipolar depressed individual.59,60,61 
Functional neuroimaging:  
 FMRI – when showing happy and sad and neutral faces, in unipolar 
depression for sad faces thers is increased amygdala activation wherin bipolar 
depression for happy faces there is activation of amygdala noted.62,63,64 
Phenomenology: 
Sociodemographic profile: 
 Age:   Mean age among various study samples around 40yrs. Age of 
people of Unipolar depression will be more than bipolar depression65 
 Age of onset:   Bipolar depression group has early age of onset  as 
compared to unipolar depression. 
 Sex:  Women are most commonly affected in unipolar depression. 
For bipolar depression, male to female ratio is 1:1. Certain studies66 
found no difference between males and females in case of bipolar 
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depression.Unipolar depression more prevalent in females. And also, 
there are evidence that bipolarity more common among males.67 
 Marital status: most of the studies, married group are common 
among unipolar depression and among bipolar depression, people are 
mostly single.68  
              A study69 showed that no significant difference observed between 
Marital status, Family type, Socio-economic status. It is found that higher socio 
economic status seen among unipolar depression thaan bipolar depression. 
Illness variables: 
Age of onset:   
 As above mentioned, bipolar depression has 6 years younger onset than 
unipolar depression. According to Perlis.et.al2, bipolar has 8 years earlier onset 
than unipolar depression. Age of onset in Bipolar depression is 20 -25 years,but 
in unipolar depression around 30-35 years. Risk of depression increases as age 
increases with peak seen in middle age and late onset of 40 years mostly in 
unipolar depression.70 
 Patel et al71 found that Early onset depression occurs prior to any life 
even like, death of family, relationship issues, failure of exams. 
  Sharma dk.et.al72 showed that Late onset depression occurs after 40 yrs 
of age. More common in people belong to low socio-economic status, divorced 
or widower, unemployed, low education status.  
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 Duration of illness and hospitalisation: 
 Increased duration of illness seen mostly among bipolar group. Length 
and duration of episode in unipolar depression more lengthy as compared to 
bipolar depression. 
 Perlis et al2, showed that greater number of episodes seen in bipolar 
group. 
 Among  bipolar depression, the episodes has rapid onset and short 
duration than unipolar depression.73 
 It is found that bipolar depression episodes will be shorter than unipolar 
depression. 
 Certain studies not showing consistent evidence about average duration 
and number of episodes.74 
              Chronic course of illness found among unipolar depression but 
multiple episodes are common in Bipolar depression.67 
 At the same time, Benazzi et al75 documented that since bipolar 
depression has early age of onset, it has more number of episodes. 
 And also, during the course of illness, full blown severe depressive 
episodes more commonly found in Bipolar depression76 
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 Mitchell et al11, concluded that bipolar depression has more life time 
depressive episodes than unipolar depression.No considerable difference found 
between age differences or duration. 
 Mitchell et al12., showed that rate of hospital admission during severe 
depression higher in bipolar than unipolar depression 
Family history 
 Considerably, from Family pedigree, psychiatric illness in first 
generation and overall family history of psychosis mostly favours 
bipolarity.75,77,78 (manning et al, akiskal et al, benazzi et al) 
Co morbities 
 Medical and psychiatric comorbities are very common with depressive 
disorders. Medical comorbities like Diabetes, Hypertension and Coronary 
artery disease often coexist with depression.  
Diabetes mellitus and Depression  
 45% of diabetes patients have depression. diabetes and depression has 
bi-directional relationship. Depression associated with 60% increase in people 
with diabetes. Diabetes associated with 15% increased risk of depression.79,80 
Comorbid depression in physical disease leads to poor outcome and vice 
versa.81 
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Figure 6, diabetes and depression 
 Stroke,Coronary heart disease, Diabetes, Hypertension all are 
increasingly associated with depression. so, in order to get good outcome, we 
need to identify both and treat accordingly. 
Thyroid dysfunction and Depression: 
 The thyroid gland is endocrine organ which is commonly involved with 
psychiatric conditions. It has two different hormones, 82 
1. Prohormone thyroxine (T4) and 
2. Triiodothyronine (T3).   
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 Hypo thalamo-pituitary adrenal axis plays a major role. The HPT axis 
was regulated by feedback mechanisms at various levels. In hypothalamus, and 
anterior pituitary inhibits TSH release and also by TRH levels. 83 
 Neuropsychiatric manifestations are very common in thyroid disorders, 
mostly mood symptoms and cognitive disturbances. Anxiety, depression and 
mood lability are common. Rarely, overt psychiatric disorder occurs. Manic 
episodes frequent in hyperthyroidism. Hypothyroidism is associated with 
depression and cognitive dysfunction.84 
Substance abuse:  
 Bipolar disorders are seven times more likely to be associated with 
substance use disorders.  Prevalence of substance use among bipolar more 
likely to be 56%.85,86  
 Individuals with depression are twice likely to have associated substance 
use problem. Overall prevalence of substance use disorders in mood disorders 
to be around 32%. Under that, 6.5% for alcohol use and 18% for any other drug 
use disorders. 87,88 
 Also people who are seeking treatment, increase number of co-
morbidity of mood disorder and substance use. Almost 20-67% experience 
depression and 6-7 % had bipolar disorder 89 
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Why substance use  so common? 
 Mood disorders and substance use both are so synergistic. Mostly, 
because of negative affective states in depression, people tend to take substance 
of various forms, in order to get relief from the symptoms . psychoactive 
substances improve affective symptoms because of dopaminergic action. 90 
 But at the same time, chronic use of substance leads to withdrawal 
symptoms and most of the time, it aggravates further mood symptoms, leads to 
chronic duration of illness and increased number of episodes.91 
 Self medication is another reason for using substance during mood 
symptom. And another reason for substance use prevalent in mood disorders as 
such changes in neurotransmitter system, abnormal signaling, and genetic 
vulnerability.92  
 But the problem which noticed in people who are taking substances for a 
long time,it unmask the mood symptoms and trigger and increase  the severity. 
It is difficult to get clear picture so leads to misdiagnosis and mal treatment, 
because substance induced withdrawal symptoms mostly depressive or manic 
or hypomanic symptoms.93 
Prevalence of substance use in mood disorders 
 Bipolar depression often associated with substance use. NESARC study 
showed that life time prevalence of occuring substance use in bipolar disorder I 
around 58% alcohol, 38% other drug use.85 
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        While comparing between Bipolar disorder Iand Bipolar disorder II, 
various  studies supported that substance use more common in bipolar disorder 
I than bipolar disorder II. 
McElroy et al94., in Bipolar disorder I,  
36%- alcohol 
40%-cannabis 
10%-cocaine 
8%-opioid  
Bipolar disorder II, 
22%- alcohol 
10%- cannabis 
4%-cocaine 
8%-opioid 
Chengappa et al95.,also showed that Bipolar disorder I  >  Bipolar disorder II 
Substance BP I BP II 
Alcohol  57.8% 38.9% 
Cannabis 19.7% 5.6% 
Cocaine 11.3% 5.6% 
Opioid 5.6% 0% 
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The Mclean Harvard first episode Mania study showed that 33% for Substance 
use disorders during index affective episode.85 
            It has found that current alcohol use disorder more prevalent in bipolar 
depressive patients.  Alcoholism more frequently found in the bipolar group 
however this difference was not significant. It found degree of substance abuse 
equal in both bipolar and unipolar groups.96 
Electroconvulsive therapy in depression: 
 One of the indication for ECT is Major Depression with Suicidal 
ideation. Sometimes, ECT mostly considered in early phase of treatment in 
melancholic depression and psychotic depression. Especially, psychotic 
features in depression respond very well to ECT.97,98,99  
 Studies showed that there is no difference in remission between unipolar 
and bipolar depression.101 
 It has found that overall improvement is quick with patients of bipolar 
depression. 
 Compared to unipolar depression, bipolar depression needs less ECT 
treatment during the course of illness. 102 
 
 
 
  
 
26
PHENOMENOLOGY 
Bipolar and Unipolar depression can be differentiated in clinical settings by 
1. Past history of hypomania or mania.  
2. Family history of bipolarity 
3. First episode of depression.11 
             “Leonhard” says about Bipolar disorder, because it is polymorphic, it 
has two poles, labile from one pole to another pole. Even though, there are 
overlapping symptoms, there has been differences,but inconsistent findings in 
previous studies. 
                Mitchell et al11., found that unipolar depression has increased 
severity,more suicidal intent, difficulty in initiating sleep- early insomnia, loss 
of weight, and somatic compliants. 
 In Bipolar Depression,  presented with mood lability, diurnal variation, 
derealization and in both unipolar and bipolar depression, psychomotor 
agitation and retardation commonly seen.103 
 Some studies showed that increased psychomotor activity in both 
cases.104 Some studies has found that psychomotor retardation most common in 
Bipolar depression.  
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              Psychomotor retardation was found to be more common and more 
severe in bipolar depression than unipolar depression. Using CORE scale, 
patient showed features like non reactive mood, masked facies, poor verbal 
response, bradykinesia, and delay in initiating action.19  
              Mood, somatic anxiety, impact on work and activities, psychic 
anxiety, gastro intestinal and somatic symptoms was associated with unipolar 
depression than with bipolar depression105. Like wise  Bipolar depression 
patients presents with atypical features like hypersomnia, excessive eating and 
hypersexuality.106  
              Features which called as bipolar signature are persistent and unvarying 
mood, subjective restlessness, leaden paralysis, hypersomnia, anticipatory 
anhedonia, worthlesness and also there is history of psychotic depression.12 
These are not pathognomic, but clinician should consider possibility of bipolar 
disorder when presented with mere symptoms. 
 Benazzi et al75., found no difference in psychomotor retardation, but 
increased atypicality in bipolar II. 
 Irritability found more in Bipolar depression than unipolar depression. 
Loss of appetite and loss of weight more common in unipolar depression. 
Difficulty in concentration also more common in unipolar than bipolar 
depression.75,106 
 Somatic complaints like something wrong with my body found more 
common in unipolar depression. 
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                 Brockington et al., showed that early depression more common in 
bipolar depression than unipolar depression. Increased activity, excessive talk, 
lability of mood also more common among bipolar depression.107 
 Overall, Psychotic features like delusions and hallucinations 
comparatively more common in bipolar depression.108 
 Olfson et al109 found that those with bipolar depression were 
significantly more likely than those with unipolar depression to report 
hallucinations, current suicidal ideation, and low esteem, but were less likely to 
acknowledge disturbed appetite. 
 Some of the studies stated that no differences in atypical depression 
found between the unipolar and bipolar depressed groups  and  that there are no   
differences in the intensity of depression between both types.110 
 Studies have found that female bipolar patients compared unipolar 
depressed patients had significantly more frequently an early age of onset of 
depression and post partum depression111. On the other end, the percentage of 
agitation, irritability, distractibility, thought racing and panic attacks during 
depression was not different in patients  with bipolar and unipolar 
depression.112 
  But, Brockington et al107., showed that auditory hallucination and 
referential ideation more prevalent among unipolar depression than bipolar 
depression. 
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 Few studies showed that  psychotic features commonly found among  
Unipolar depression who convert into bipolar depression.113, 114,115Venkoba Rao 
et al., stated  that considering the occurrence of affective disorder in the other 
first degree relation, the study failed to reveal any differences between unipolar 
and bipolar disorder.116 
Suicidal ideation: 
 Suicide is major concern for people with psychiatric disorders. 90% 
suicide more common in psychiatric disorders. Most common being major 
depression and bipolar disorders which accounts for around 60%. Among 
bipolar disorders, risk of suicide is 20-30 times greater than normal population. 
In that also, bipolar disorder II has increased risk than bipolar disorder I.117 
 Studies showed that serious suicide attempt and family history of suicide 
are closely associated with diagnosis of bipolar depression. Number of suicidal 
attempts more common among bipolar disorder than in unipolar disorder 118 
 Suicide attempters showed significantly higher rates of atypical 
depression.  Bipolar suicide attempters had more life time episodes of major 
depression compare to bipolar non-attempters. 
 Brockington et al107, (1982) found that suicidal ideation score more in 
unipolar depressed patients compared to bipolar patients.  
 
    
 
30
 
 
 
 
 
 
 
 
 
          
 Some studies also found that maximum length of suicidal acts tended to 
be higher among bipolar depressed attempters compared to those with unipolar 
depressed attempters. It also showed that suicidal ideation and psychomotor 
disturbance more likely to be found across in all levels of severity of 
depression in bipolar versus unipolar depression.119 
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Predictors of bipolarity: 
 Angst and preisig et al120., showed that almost 1% patients diagnosed as 
unipolar depression , after hospitalisation and treatment, switched to Bipolar 
disorder-I every year. 
 Studies have mentioned that certain variables as predictors of bipolarity, 
which includes early age of onset, family history of mood disorder, switching 
to manic episodes by antidepressant use, onset following postpartum, mixed 
episodes, suicidal attempts, atypical symptoms.  121 
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AIM AND OBJECTIVES 
1. To assess Psycho-socio-demographic profile and Clinical profile of 
patients with bipolar depression and unipolar depression. 
2. To assess Substance use among patients with bipolar depression and 
unipolar depression. 
3. To assess predictors of bipolarity. 
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METHODOLOGY 
 STUDY POPULATION AND STUDY PLACE: 
             The study population consists of patients attending out-patient clinic 
and in-patient wards of Department of Psychiatry, Institute of Mental Health, 
Kilpauk. 
 
STUDY DESIGN: 
                  Comparative Cross- sectional study 
SAMPLE SIZE: 100 
                      50 patients in unipolar depression group 
                      50 patients in bipolar depression group 
DURATION OF STUDY:  
             6 months from the date of approval of ethical committee. 
INCLUSION CRITERIA: 
1) 20-50 years of age 
2) Both gender 
3) Patient diagnosed with bipolar affective disorder or recurrent 
depressive disorder, currently with moderate/ severe depression, 
with/without somatic syndrome, and wit/without psychotic 
symptoms. 
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EXCLUSION CRITERIA: 
1) People with Mental retardation, Seizure disorder, Dementia, and other 
psychiatric conditions like schizophrenia, anxiety disorders. 
2) Patients who have not given consent 
3) Patients who cannot provide adequate information. 
Methodology:  
         Patients whoever attending out-patient and in-patient clinic of Institute 
of Mental Health, Kilpauk, who were diagnosed with Bipolar Affective 
Disorder or Recurrent depressive disorder, currently presents with depressive 
episode with/ without somatic syndrome, and with/without psychotic symptom, 
using ICD-10 criteria, and those who met inclusion criteria were included in 
the study. Informed consent obtained from the patients who were included.  
 Detailed history was taken from each patient regarding episodes and 
course of illness. 
 Semi-Structured Proforma was applied for assessing socio-demographic 
parameters and illness parameters and scales given for quantifying depression 
and psychotic features. 
 Socio-demographic profile includes biographical data and  
socio-economic status was assessed using MODIFIED KUPPUSWAMI 
SOCIO-ECONOMIC STATUS scale and illness parameters include  
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1. Age of onset,  
2. Total duration of illness,  
3. Number of hospitalisations,  
4. Family history of illness,  
5. Medical co-morbities,  
6. Postpartum onset,  
7. History of ECT  all were assessed. 
 Along with that, to compare substance use like alcohol, cannabis, 
nicotine between unipolar and bipolar depression. 
Regarding phenomenology, 
1. Sleep pattern,   
2. Appetite changes,  
3. Guilt feelings, 
4. Irritability,  
5. Ideas of helplessness,  
6. Hopelessness, 
7.  Worthlessness,  
8. Decreased concentration, decreased attention, forgetfulness,  
9. Psychomotor activity,  
10. Low self esteem  
11.  Catatonic features,  
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12.  Anhedonia,  
13. Deliberate self -harm, suicidal ideas, suicidal attempts, 
14. Dissociative features, anxiety features,  
15. Psychotic features like delusions, hallucinations between 
unipolar depression and bipolar depression were assessed. 
SCALES USED: 
1. HAMILTON RATING SCALE FOR DEPRESSION(HAM-D) 
2. BRIEF PSYCHIATRIC RATING SCALE (BPRS) 
3. ALCOHOL USE DISORDERS IDENTIFICATION TEST 
(AUDIT) 
4. FAGERSTROM TEST FOR NICOTINE DEPENDANCE 
5. MODIFIED KUPPUSAMY SCALE 
 The above, mentioned scales were applied to each patient to quantify the 
severity of depression and elicit the substance use pattern.  
HAMILTON RATING SCALE FOR DEPRESSION: 
 It is mostly widely used and developed by Max Hamilton in 1960. It is 
multidimensional scale. It contains 17 items to assess symptoms of depression 
over past week, especially designed for hospital inpatients. Later, 21- item 
version added. For scoring, score of 0–7 – normal range (or in clinical 
remission), 8-13-mild depression; 14-18- moderate depression; 19-22- severe 
depression, >23- very severe depression. It has internal consistency varies from 
0.48-0.92. It has high inter-rater reliability of 0.80-0.98. 122,123 
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BRIEF PSYCHIATRIC RATING SCALE: 
 It was designed by Overall and Gorham to assess overall 
psychopathology in major psychiatric disorders, particularly psychosis. It 
remains one of most widely used clinician administered tool for evaluating 
baseline psychopathology. 124,125  
ALCOHOL USE DISORDERS IDENTIFICATION TEST: 
 It is gold standard rating scale developed by WHO. It is reliable and 
valid measure in identifying alcohol use behavior. It measures different 
domains of alcohol consumption. 126 
1-3 questions for assessing frequency in alcohol consumption 
4-6 questions to measure alcohol dependence 
7-10 questions to measure alcohol related problems 
 For interpretation of scoring, score of 8 in men suggest harmful drinking 
and score of more than 20 likely to be dependence. It has been found to be both 
sensitive and specific in detection of alcohol use related disorders.127 
FAGERSTROM TEST FOR NICOTINE DEPENDANCE: 
 It is brief 6-item scale that gives quantitative measure of nicotine 
dependence. It has internal consistency of 0.68.128,129. 
 Interpretation:  score of 0-2 very low; 3-4- low; 5- moderate 6-7- high; 
8-10- very high.  Score of 6 or high indicates of high nicotine dependence.    
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STATISTICAL ANALYSIS 
 The Normality tests Kolmogorov-Smirnov and Shapiro-Wilks tests 
results reveal that some variables follow Normal distribution and few variables 
(Duration, no of episodes and no of hospitalizations) do not follow normal 
distribution. Therefore, to analyse the data both parametric and non-parametric 
methods are applied. For variables which follow Normal distribution, to 
compare mean values between BPD and UPD independent samples t-test is 
applied. To compare values of Duration, no of episodes and no of 
hospitalizations (Non-Normal variates) between BPD and UPD Mann Whitney 
test is applied. To compare proportions between BPD and UPD groups  
Chi-Square test is applied, if any expected cell frequency is less than five then 
Fisher’s exact test is used. To analyse the data SPSS (IBM SPSS Statistics for 
Windows, Version 23.0, Armonk, NY: IBM Corp. Released 2015) is used. 
Significance level is fixed as 5% (α = 0.05). Logistic regression analysis has 
done to identify predictors for bipolarity using odds ratio.    
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Table – 2 
Comparison of Socio demographic variables between two groups: 
 
Variables  Group 
 BPD UPD P value  
 N % N %  
Gender   
Male 28 65.1% 15 34.9%  
Female 22 38.6% 35 61.4%  
Total 50 50.0% 50 50.0% 0.09*** 
Religion  
Hindu 37 46.3% 43 53.8%  
Islam 5 55.6% 4 44.4%  
Christianism 8 72.7% 3 27.3%  
Total 50 50.0% 50 50.0% 0.286 
SES  
Lower 5 41.7% 7 58.3%  
Upper lower 29 54.7% 24 45.3%  
Lower middle 13 52.0% 12 48.0%  
Upper middle 3 30.0% 7 70.0%  
Total 50 50.0% 50 50.0% 0.485 
 
        **** - p value - < 0.05 is significant.  
 
 In above Table-2, socio-demographic variables were compared between 
Unipolar and bipolar depression. On comparing Marital status, Family type, 
Marital status  
Married 32 45.1% 39 54.9%  
Unmarried 17 63.0% 10 37.0%  
Others 1 50.0% 1 50.0%  
Total 50 50.0% 50 50.0% 0.217 
Family type  
Nuclear 30 44.1% 38 55.9%  
Joint 15 71.4% 6 28.6%  
Extended 5 45.5% 6 54.5%  
Total 50 50.0% 50 50.0% 0.087 
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TABLE 4: COMPARISON OF ILLNESS PARAMETERS BETWEEN 
UNIPOLAR AND BIPOLAR DEPRESSION: 
 
 
 
Group 
Z-value p-value 
BPD UPD 
Duration 
(years) 
N 50 50
2.345 0.019*** 
Mean 8.9 6.2
Std. Dev 6.30 5.31
Median 8.0 5.0
1st Quartile 3.0 2.0
3rd Quartile 
 
12.0 8.0
No. of 
episodes 
N 50 50
2.540 0.011*** 
Mean 3.3 2.9
Std. Dev 1.59 2.24
Median 3.0 2.0
1st Quartile 2.0 2.0
3rd Quartile 4.0 3.0
No. of 
hospitalisatio
ns 
N 50 50
2.307 0.021*** 
Mean 1.0 .6
Std. Dev 1.12 1.24
Median 1.0 .0
1st Quartile .0 .0
3rd Quartile 2.0 1.0
 
***-p<0.05 – significant  
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BOX AND WHISKER PLOT FOR COMPARISON OF DURATION OF 
ILLNESS BETWEEN TWO GROUPS: 
 
 Duration of illness was compared between bipolar depression and 
unipolar depression which showed that bipolar depression has long years of 
duration of illness (8.9years) than unipolar depression (6.2 years). It was found 
to be statistically significant (P=0.019) 
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BOX AND WHISKER PLOT FOR COMPARISON BETWEEN 
NUMBER OF EPISODES BETWEEN TWO GROUPS: 
 
 
 In Above diagram, Number of episodes were compared between 
unipolar depression and bipolar depression, found that number of episodes 
were seen higher among bipolar depression (3.3) than unipolar depression 
(2.9), which was statistically significant. 
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BOX AND WHISKER PLOT FOR COMPARISON BETWEEN 
NUMBER OF HOSPITALISATIONS BETWEEN TWO GROUPS: 
 
 
 Number of hospitalisations in bipolar depression were compared with 
unipolar depression in the above diagram, showed that number of 
hospitalisation were higher in bipolar depression (1.0), than unipolar 
depression (.6) which was found to be statistically significant (P=0.021) 
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Table 5: FAMILY HISTORY OF ILLNESS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
****- p value<0.05  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mood 
Group 
BPD UPD P value  
N % N %  
No 33 48.5% 35 51.5%  
Yes 17 53.1% 15 46.9%  
Total 50 50.0% 50 50.0% 0.668 Psychosis   
No 47 50.5% 46 49.5%  
Yes 3 42.9% 4 57.1% 0.999 
Total 50 50.0% 50 50.0%  
Suicide   
No 33 45.2% 40 54.8%  
Yes 17 63.0% 10 37.0% 0.115 
Total 50 50.0% 50 50.0%  
Substance use  
No 19 39.6% 29 60.4%  
Yes 31 59.6% 21 40.4%  
Total 50 50.0% 50 50.0% 0.045*** 
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Table 6: COMPARISON OF CO-MORBID MEDICAL  
ILLNESS AMONG 2 GROUPS: 
 Diabetes 
Group 
BPD UPD P value  
N % N %  
No 42 56.8% 32 43.2% 
Yes 8 30.8% 18 69.2% 
Total 50 50.0% 50 50.0% 0.023***
        Hypothyroid   
No 36 58.1% 26 41.9% 
Yes 14 36.8% 24 63.2% 
Total 50 50.0% 50 50.0% 0.039***
       Hypertension   
No 46 52.3% 42 47.7% 
Yes 4 33.3% 8 66.7% 
Total 50 50.0% 50 50.0% 0.218
***P<0.05 significant  
   
People with unipolar depression (69.2%) has more association with diabetes 
than bipolar  depression (30.8%) which was found to be statistically significant. 
(p-0.03). 
 Unipolar depression (63.2%) group has higher association with co 
morbid hypothroidism as compared to Bipolar depression group (36.8%), 
which was also  found to be statistically significant (p-0.039). There were no 
significant differences found for hypertension between two groups. 
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TABLE 7: COMPARISON OF ILLNESS PARAMETERS  
BETWEEN TWO GROUPS: 
 
Postpartum 
Group 
BPD UPD P value  
N % N %  
No 18 35.3% 33 64.7%  
Yes 3 75.0% 1 25.0%  
NA 29 64.4% 16 35.6%  
Total 50 50.0% 50 50.0% 0.007*** 
ECT 
No 44 46.8% 50 53.2%  
Yes 6 100.0% 0 0.0%  
Total 50 50.0% 50 50.0% 0.027*** 
 
***- p<0.05 is significant  
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 Table 8:  COMPARISON OF SUBSTANCE USE AMONG 2 
GROUPS: 
 
Alcohol 
Group 
BPD UPD P value  
N % N %  
No use 26 38.8% 41 61.2%
Abuse 6 50.0% 6 50.0%
Dependence 18 85.7% 3 14.3%
Total 50 50.0% 50 50.0% 0.001***
       Nicotine  
No use 27 40.3% 40 59.7%
Abuse 0 0.0% 2 100.0%
Dependence 23 74.2% 8 25.8%
Total 50 50.0% 50 50.0% 0.001***
      Cannabis  
No use 42 45.7% 50 54.3%
Dependence 8 100.0% 0 0.0%
Total 50 50.0% 50 50.0% 0.006***
 
 
***- p<0.05 – significant 
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TABLE 9:  COMPARISON OF DEPRESSIVE SYMPTOMS  
BETWEEN TWO GROUPS: 
Sleep 
Group 
BPD UPD P value  
N % N %  
Insomnia 46 47.9% 50 52.1%  
Hypersomnia 4 100.0% 0 0.0%  
Total 50 50.0% 50 50.0% 0.117 
         Appetite   
Decreased 30 37.5% 50 62.5%  
Increased 20 100.0% 0 0.0%  
Total 50 50.0% 50 50.0% <0.001*** 
        Guilt   
No 31 43.7% 40 56.3%  
Yes 19 65.5% 10 34.5%  
Total  50 50.0% 50 50.0% 0.047*** 
       Irritability  
No 0 0.0% 41 100.0%  
Yes 50 84.7% 9 15.3%  
Total 50 50.0% 50 50.0% <0.001*** 
 
*** p<0.05- significant  
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helplessness found higher among unipolar depression than bipolar depression, 
which was found to be statistically significant. p=0.059 
TABLE 12: COMPARISON OF PSYCHOMOTOR ACTIVITY 
BETWEEN TWO GROUPS: 
 
PMA-Agitated 
Group 
BPD UPD P value  
N % N %  
No 24 33.8% 47 66.2%
Yes 26 89.7% 3 10.3%
Total 50 50.0% 50 50.0% <0.001***
PMA-Retarded 
Group 
BPD UPD P value  
N % N %  
No 28 84.8% 5 15.2%
Yes 22 32.8% 45 67.2%
Total 50 50.0% 50 50.0% <0.001***
  
***- p<0.05- significant. 
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TABLE 13: COMPARISON OF SUICIDAL IDEAS AND  
ATTEMPTS BETWEEN 2 GROUPS 
Suicidal ideas 
Group 
 
BPD UPD P value 
N % N %  
No 15 50.0% 15 50.0%  
Yes 35 50.0% 35 50.0%  
Total 50 50.0% 50 50.0% 1.000 
Suicidal attempt 
Group 
BPD UPD P value 
N % N %  
No 31 47.0% 35 53.0%  
Yes 19 55.9% 15 44.1%  
Total 50 50.0% 50 50.0% 0.398 
DSH 
Group 
BPD UPD P value 
N % N %  
No 18 31.0% 40 69.0%  
Yes 32 76.2% 10 23.8%  
Total 50 50.0% 50 50.0% <0.001*** 
***- p value<0.05- significant 
         On Comparing suicidal ideas, suicidal attempts and deliberate self-harm 
between two groups showed that Deliberate self-harm was found higher in 
bipolar depression of around 76% as compared to unipolar depression of 
around 23.8%, which was found to be statistically significant (p=<0.001)
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TABLE 14: COMPARISON OF SYMPTOMS BETWEEN 2 GROUPS  
Anhedonia 
 Group 
BPD UPD P value 
N % N %  
No 11 57.9% 8 42.1%
Yes 39 48.1% 42 51.9%
Total 50 50.0% 50 50.0% 0.444
Low self-esteem 
No 20 44.4% 25 55.6%
Yes 30 54.5% 25 45.5%
Total 50 50.0% 50 50.0% 0.315
    Anxiety  
No 45 47.4% 50 52.6%
Yes 5 100.0% 0 0.0%
Total 50 50.0% 50 50.0% 0.056***
 
***- p value<0.05- significant 
 On comparing symptoms like anhedonia, low self-esteem, and anxiety 
features between two groups, showed that  Anxiety features was found 
significantly higher among  bipolar depression(n=5) as compared to unipolar 
depression, which was found to be  statistically significant(p=0.056).  
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TABLE 15: COMPARISON OF PSYCHOTIC  
FEATURES BETWEEN TWO GROUPS 
Delusion 
Group 
BPD UPD     P value  
N % N %  
No 22 33.3% 44 66.7%  
Yes 28 82.4% 6 17.6%  
Total 50 50.0% 50 50.0% <0.001 
Hallucination 
Group 
BPD UPD P value 
N % N %  
No 22 32.8% 45 67.2%  
Yes 28 84.8% 5 15.2%  
Total 50 50.0% 50 50.0% <0.001 
 
***- p<0.05- significant. 
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Table 16: 
  
COMPARISON OF SCALES TO ASSESS ILLNESS SEVERITY  
BETWEEN TWO GROUPS 
 
 
Variables Group N Mean Std. Dev t-value p-value 
HAM-D BPD 50 17.14 3.393
0.320 0.750 
UPD 50 17.44 5.704
BPRS BPD 32 29.84 7.243
1.853 0.093 
UPD 9 22.67 10.966
  
       Above table compared the illness severity using standard rating scales 
between two groups which revealed that HAM-D scores suggestive of 
moderate to severe depression in both groups with mean of 17.74, hence no 
difference between severity of depression between two groups.  BPRS scale to 
assess psychotic symptoms severity showed mean score around 29 in bipolar 
depression and 22 in unipolar depression, hence no significant statistical 
differences elicited between 2 groups.  
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Table 17: COMPARISON OF SCALES USING SUBSTANCE USE 
SEVERITY BETWEEN TWO GROUPS 
Variables Group N Mean Std. dev t-value p-value 
Audit BPD 24 21.00 7.151
2.326 0.027*** 
UPD 8 14.25 6.964
Fagerstrom BPD 23 8.35 1.695
0.470 0.642 
UPD 9 8.67 1.803
 
*** P<0.05 – statistically significant.   
 Above table, compare the severity of substance use pattern among two 
groups using rating scales, revealed that Bipolar depression group has 
increased scores  on AUDIT scales as compared to unipolar depression group, 
which was found to be statistically significant. P=0.027 
 On Fagerstrom scale for nicotine dependence, showed mean score of 
around 8 in both groups, which was not statistically significant.  
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TABLE 18: LOGISTIC REGRESSION TO FIND OUT 
PREDICTORS OF BIPOLARITY: 
Factors 
BPD 
Odds 
R
a
ti
o
95% CI for 
OR 
p-value 
N % LL UL 
Male 28 65.1% 2.97 1.304 6.764 0.010***
F/H/O substance 31 59.6% 2.25 1.011 5.019 0.047***
Alcohol Abuse 6 50.0% 1.58 .459 5.415 0.469
Alcohol   
Dependence 
18 85.7% 9.46 2.534 35.324 0.001***
Guilt  19 65.5% 2.45 0.999 6.018 0.050***
Forgetfulness  37 57.8% 2.43 1.045 5.626 0.039***
PMA Agitated  26 89.7% 16.97 4.661 61.798 <0.001***
DSH 32 76.2% 7.11 2.885 17.526 <0.001***
Delusion  28 82.4% 9.33 3.367 25.870 <0.001***
Hallucination  28 84.8% 11.46 3.892 33.715 <0.001***
 
*** p<0.05- significant 
 Above table, listed out variables which was found significant differences 
between two groups were analysed using logistic regression to find out 
predictors of bipolarity.  It showed that, male gender has two-fold increase risk 
for bipolarity.   
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 Family history of substance use has two-fold risk for bipolarity. People 
with alcohol dependence has 9-fold more risk for bipolarity. 
   Symptoms like ideas of guilt and memory disturbances has 2- fold risk 
for bipolarity. People presented with Psychomotor agitation has 16-fold 
increased risk for bipolarity. People with deliberate self-harm during course of 
illness has 7-fold high risk for bipolarity.  
 Psychotic symptoms like delusions and hallucinations in depression 
carries 10-fold increased risk for bipolar spectrum disorders. 
. 
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              DISCUSSION 
 
 The aim of this study was to assess the socio demographic profile and 
clinical features  and substance use of unipolar depression and bipolar 
depression.  
        Bipolar depression and unipolar depression   have overlapping clinical 
symptoms and presentation, which often leads to misdiagnosis and inadequate 
treatment. As, both have different treatment guidelines, early detection of signs 
and symptoms would prevent inadequate treatment.  
         In our study, regarding mean age of presentation, bipolar depression 
group was found to be younger compared to unipolar depression group. This 
result was consistent with previous studies done by Mitchell et al130., Solomon 
et al131., Szeman et al132., Nisha A et al133., 
          Age of onset of illness in both groups, had showed that bipolar 
depression group had younger age of onset than unipolar depression group. 
This result was consistent with previous studies done by Abrams R et al134., 
Anderson et al65, Solomon et al131., Weissman et al70., Nisha A et al134.,  
 In our study, unipolar depression was found to be more common in 
females and bipolar depression was found to be more common among males. A 
study done by Leibenluft et al135 stated that prevalence of depression and rapid 
cycling course found to be more common among women.        
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In our study, most of the people belonged to lower socio-economic status. No 
significant difference was noticed between both the groups. Other socio-
demographic variables such as marital status, family type and religion showed 
no significant differences between two groups. But study done by Nunez et 
al68, had shown contrasting result from our study where unipolar depression 
people were married and most of the bipolar depression people were single. 
Illness variables: 
 Our study showed that bipolar depression had long duration of illness 
and increased frequency of episodes and a greater number of hospitalisations as 
compared to unipolar depression. These results were consistent with previous 
studies done by Perlis et al2., Roybyrne et all73., Miller et al12., Winokur et al95., 
Benazzi et al75., Leonpacher A K et al.,136 
 But study done by Mitchell11 et al showed that episode of bipolar 
depression will be shorter and rapid onset, but unipolar depression has chronic 
course. 
 Regarding, family history our study showed that bipolar depression 
group had family history of substance use significantly more compared to 
unipolar depression group.   
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 Our study did not show any significant differences for family history of 
mood, psychosis and suicide between two groups. But previous studies done by 
Benazzi et al75., Manning et al77., Akiskal et al78., showed that patients with 
bipolar depression has family history of psychosis and mood disorders, more 
common among first generation relatives, which is contradictory in our study. 
 In our study, we assessed co morbid medical conditions like 
hypertension, diabetes and hypothyroidism among unipolar and bipolar 
depression. There were no significant differences noted for hypertension. But 
presence of Diabetes was found to be significantly higher among unipolar 
depression group than bipolar depression group. 
This result consistent with previous study by Mezuk et al79., 
 On contrary to our study, Calvin cv et al137., in his study showed that 
bipolarity was associated with both pre-diabetes and diabetes, and the reason he 
stated for this result was because of wide usage of mood stabilisers and 
antipsychotics in bipolar disorder leads to complication of metabolic syndrome, 
hence diabetes found more common among bipolar group.  
 Individuals having unipolar depression were found to have significant 
association with co morbid hypothyroidism, compared to bipolar depression 
group in our study. This result was consistent with previous studies done by 
Bauer et al82., Hendrick et al83.,  
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 But study done by Chakrabarti et al138 stated that rarely hypomanic or 
manic symptoms associated with hypothyroidism, most often hyperthyroidism 
has associated with bipolar depression.  
Substance use: 
 Our study showed that greater number of people from bipolar depression 
group had alcohol, cannabis, and nicotine dependence compared to people from 
unipolar depression group. And regarding severity of alcohol use and nicotine 
use, there was no significant differences noted between two groups. 
 These results were consistent with previous studies done by Olfsun et 
al109., Winokaur et al96., Moreno et al90., 
 McElroy et al94., and Chengappa et al95., showed that more people from 
Bipolar disorder I had substance dependence compared to Bipolar disorder II. 
 Our study showed that postpartum onset of depression was mostly 
associated with bipolarity, we had few numbers of cases reported to have 
postpartum onset. This result was consistent with previous study done by 
Rybakowski J et al111.  
Phenomenology: 
 In our study we have compared symptomatology between unipolar and 
bipolar depression. There was no significant differences found with respect to  
loss of appetite and insomnia between two groups in our study. But among 
Atypical symptoms like Hyperphagia was significantly found to be more 
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among bipolar depression. This result was consistent with previous studies 
done by Vieta et al111 and Mitchell et al11.,  
                   But, studies done by Mitchell et al130., had showed that atypical 
features like hypersomnia, hyperphagia, and hypersexuality most commonly 
associated with Bipolar depression, which was different from our study. 
 Our study showed that Irritability and guilt feelings significantly found 
higher in bipolar depression than unipolar depression. These results were 
consistent with previous study done by Benazzi et al75., 
 Cognitive symptoms like memory disturbances, decreased attention and 
decreased concentration was studied between two groups. Our study showed 
that memory disturbances was found to be more common among bipolar 
depression group as compared to unipolar depression group.  
 Our study did not show any significant differences between inattention 
and decreased concentration. But study done by Abrams and taylor et al134. and 
papadimitiou et al106., showed that difficulty in concentration and attention was 
more common among unipolar depression group, which was in contrary to our 
study. 
 Regarding depressive symptoms, our study showed that Ideas of 
helplessness was found to be significantly higher among unipolar depression 
group than bipolar depression group. But Miller et al12., stated that Ideas of 
helplessness, hopelessness, worthlessness found to be more common in 
unipolar depression, which was different from our study. 
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 In Our study, psychomotor retardation was found to be significantly 
more common among unipolar depression group and psychomotor agitation 
was found to be more in bipolar depression group. This result was consistent 
with previous study done by Beigel et al104.,  
 But study done by Goodwin and Jamison et al19., found that 
psychomotor retardation was significantly higher in bipolar depression than 
unipolar depression. Another study, which was done by Benazzi et al75., stated 
that there was no significant difference found between two groups for 
psychomotor retardation. 
 In our study, Deliberate self-harm had higher association with bipolar 
depression group than unipolar depression group, which could  probably be due 
to influence of other factors like personality and substance use.  
 Our study did not show any significant differences between suicidal 
ideations and suicidal attempts. But previous studies done by Leonpacher A K 
et al.,136 
 Oquendo MA et al139., Schaffer A et al117., Hawton K et al119., showed 
that a greater number of suicidal attempts and suicidal thoughts found to be 
more common among bipolar depression, which is differed from our result. 
 Anhedonia was equally seen in both unipolar depression and bipolar 
depression group.  Mitchell et al11., found a contrasting result from our study, 
he showed that anticipatory anhedonia could be a signature symptom of bipolar 
depression. 
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 Anxiety symptoms were found to be significantly higher among bipolar 
group in our study. This result was consistent with previous studies done by 
Vieta et al111., Mitchell et al130., Leonpacher A K et al.,136 
 Our study showed that psychotic symptoms like delusions and 
hallucinations were found to be significantly higher among bipolar depression 
group than unipolar depression group. These results were consistent with 
previous studies done by Olfson et al109., Miller et al130., But, one study done 
by Brockington et al107., showed that auditory hallucination and ideas of 
reference were common among unipolar depression group than bipolar 
depression group which was different from our results.  
Predictors of bipolarity: 
 In our study, logistic regression was applied for variables which had 
significant association between two unipolar depression and bipolar depression 
group.  From this analysis, variables that could predict bipolarity were found.  
Those variables are                       
1) Male gender 
2) Family history of Substance use  
3) Postpartum onset 
4) H/O alcohol dependence and abuse   
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5) Guilt feelings 
6) Forgetfulness 
7) Psychomotor agitation 
8) Deliberate self-harm 
9) Delusion and hallucinations. 
 
These results consistent with previous studies done by Coryell et al74., gold 
berg et al112., Leonpacher AK et al136., Strober et al140., 
 A Study done by Akiskal et al141., showed some of features like  
1)  early onset, 
2)  family history of bipolar disorder,  
3) anti-depressant induced manic-episode,  
4) following postpartum onset 
 were mentioned as common predictors, slightly different from our study. The 
reason would be as we did not assess about the history of anti-depressant 
following manic episode among people with bipolar depression group. 
 Another study done by Mitchell et al130., showed that predictors of 
bipolarity in their study which was different from our study results. 
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The predictors were   
1) early morning awakening 
2) difficulty in concentration  
3) diurnal variation- symptoms increased in morning 
4) psychotic symptoms 
5) mixed symptoms. 
 
             There were no significant differences in severity of depression between 
both the groups based on HAM-D, in our study. 
 But a study done by Heger U et al76., mentioned that severity of 
depression was noticed higher among bipolar depression group compared to 
unipolar depression group.  
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LIMITATIONS 
1. This is cross- sectional study. Our study had lesser sample size, so not 
generalized to general population  
2. As it was cross-sectional study, the prognosis and episode severity and 
duration of each episode, course and prognosis of disease were not 
assessed. Anti-depressant induced manic episodes were not elicited. 
3. Relation of co-morbid physical illness and substance use to the illness 
was not assessed. 
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CONCLUSION 
 
  Certain socio demographic and clinical variables differ between people 
having unipolar depression and bipolar depression. Detailed history and proper 
clinical assessment during first episode of depression would help to predict 
occurence of bipolarity. By early identification of bipolarity spectrum, course 
and severity of disease can be modified by appropriate treatment. It would also 
help to prevent further episodes. It could also improve the overall psychosocial 
functioning and quality of life of such patients. 
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                                FUTURE DIRECTIONS 
 
 
 As there are paucity of Indian studies related to neurobiological and 
structural and functional neuroimaging difference between unipolar and bipolar 
depression, so future studies should focus more on this basis. 
 Studies should also be done to identify bio markers that determine the 
bipolar depression in early stages.  
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மருத்துவ சுயவிவரம் மற்றும் உளவியல் சமூக காரணிகைள ஒப்பியல் 
ெசய்யப்படுகிறது.இவ்விரண்டு பிணியாளர்களிைடேய மருத்துவ அறிகுறிகள் 
ெதன்படுவதிலும்,ேநாைய கண்டறிவதிலும் குறிப்பிடத்தக்க ேவறுபாடுகள் உள்ளன.ேமலும் இந்த 
ஆய்வில் மட்டுமீறிய ேபாைத ெபாருள் நுகர்தல் மற்றும் சிகிச்ைசகளின் விைளவுகைளயும் 
ஆராய்ந்து ஒப்படீு ெசய்யப்படுகிறது. 
ெசய்முைற விளக்கம்: 
              இந்த ஆய்வு மனநல காப்பகத்தில் புறேநாயாகளிள் பிrவில் நைடெபறுகிறது. இந்த ஆய்வில் 
பிணியாளர்களின் முழு சம்மதத்துடன் உட்படத்தபடுவார்கள்.இவர்களுக்க HAM-D, HCL-
32,BPRS,KUPPUSWAMI SOCIOECONOMIC STATUS SCALE,AUDIT ேபான்ற ேகள்வி தாள் மூலம் மதிப்படீு 
ெசய்யப்படும். 
ஆய்வினால் தாங்கள் அைடயும் பயன்கள்:  சுய தீங்கிற்கான ஆபத்து காரணிகள் தங்களிடம் 
கண்டறியப் பட்டால் அதற்குrய சிகிச்ைச தங்களுக்கு அளிக்கப்படும். 
தகவலின் இரகசிய தன்ைம:  தங்களுைடய சுயவிளக்கம்,மருத்துவக் குறிப்புகள் மற்றும் மருத்துவ 
ேசாதைன அறிக்ைக அைனத்தும் ரககியமாக ைவப்பதற்கு தனியுrைம அளிக்கப்படும்.இதன் 
முடிவுகைள ெவளியிடும் ேபாேதா அல்லது ஆய்வின் ேபாேதா தங்களது ெபயைரேயா, 
அைடயாளங்கைளேயா ெவளியிடமாட்ேடாம் என்பைதயும் ெதrவித்துக்ெகாள்கிேறாம். 
              இந்த ஆய்வில் தாங்கள் பங்ேகற்காவிட்டாலும் தங்களுைடய மருத்துவ உதவியில் 
எந்தெவாரு பின்விைளவுகளும் ஏற்படாது. 
              இந்த ஆய்வில் பங்ேகற்பது தங்களுைடய விருப்பத்தின் ேபrல் தான் ேமலும் நீங்கள் 
எந்ேநரமும் இந்த ஆய்விலிருந்து பின்வாங்கலாம் என்பைதயும் ெதrவித்துக்ெகாள்கிேறன். 
 
ஆய்வாளrன் ைகெயாப்பம்                                           பங்ேகற்பாளர் ைகப்ெயாப்பம் 
 
 
நாள்:                                                                நாள்: 
 Name 
Age 
Sex:    M/F 
Education 
Occupation 
Income 
Marital status  
Socioeconomic status 
Religion 
Family type 
Place 
Informant 
 
Illness parameters: 
 
1. Age of onset- 
2. Total duration- 
3. No.of. episodes- 
4. No.of. hospitalisation- 
5. Family history of illness- similar illness/psychotic illness/suicide/substance use 
6. Medical co morbidity- HTN/DM/HYPOTHYROID/OTHERS 
7. POSTPARTUM onset 
8. Peri menopausal onset 
9. H/O ECT 
10. SUBSTANCE USE:    Alcohol abuse/dependence  
                                   Nicotine abuse/dependence 
                                    Cannabis abuse/dependence 
 
Phenomenology: 
 
1) Depressed cognition-  forgetfulness/ reduced concentration/ reduced attention 
2) Psychomotor activity- retarded/ agitated 
3) Catatonic features- yes/no 
4) Suicidal thoughts/ ideations/ plans- 
5) Suicidal attempts- 
6) Deliberate self harm- 
7) Anhedonia- 
8) Dissociative features 
9) Panic symptoms 
10) Psychotic symptoms  
 Delusions-  
persecutory/referential/guilt/infidelity/hypochondriacal/nihilistic 
 
 First rank symptoms-thought echo/ broadcasting/insertion 
 
 Hallucinations- auditory (1st/2nd/3rd) 
The Alcohol Use Disorders Identification Test: Interview Version 
 
Read questions as written. Record answers carefully. Begin the AUDIT by saying  
“Now I am going to ask you some questions about your use of alcoholic beverages during this past 
year.” Explain what is meant by “alcoholic beverages” by using local examples of beer, wine, vodka, 
etc. Code answers in terms of “standard drinks”. Place the correct answer number in the box at the 
right. 
 
1. How often do you have a drink containing alco- 6. How often during the last year have you needed  
 
hol? a first drink in the morning to get yourself going  
 
(0) Never [Skip to Qs 9-10] after a heavy drinking session?        
(1) Monthly or less (0) Never  
 
(2) 2 to 4 times a month (1) Less than monthly  
 
(3) 2 to 3 times a week (2) Monthly  
 
(4) 4 or more times a week   (3) Weekly   
 
    (4) Daily or almost daily   
 
  
 
2. How many drinks containing alcohol do you have 7. How often during the last year have you had a  
 
on a typical day when you are drinking? feeling of guilt or remorse after drinking?  
 
(0) 1 or 2 (0) Never  
 
(1) 3 or 4 (1) Less than monthly  
 
(2) 5 or 6 (2) Monthly  
 
(3) 7, 8, or 9   (3) Weekly   
 
(4) 10 or more   (4) Daily or almost daily   
 
   
 
3. How often do you have six or more drinks on one 8. How often during the last year have you been  
 
occasion? unable to remember what happened the night  
 
(0) Never before because you had been drinking?        
(1) Less than monthly (0) Never  
 
(2) Monthly (1) Less than monthly  
 
(3) Weekly (2) Monthly  
 
(4) Daily or almost daily (3) Weekly  
 
Skip to Questions 9 and 10 if Total Score   (4) Daily or almost daily                
for Questions 2 and 3 = 0       
 
  
 
4. How often during the last year have you found 9. Have you or someone else been injured as a  
 
that you were not able to stop drinking once you result of your drinking?  
 
had started? (0) No         
(0) Never (2) Yes, but not in the last year  
 
(1) Less than monthly (4) Yes, during the last year  
 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
5. How often during the last year have you failed to 10. Has a relative or friend or a doctor or another 
do what was normally expected from you health worker been concerned about your drink- 
because of drinking? ing or suggested you cut down?
(0) Never (0) No
(1) Less than monthly (2) Yes, but not in the last year
(2) Monthly (4) Yes, during the last year
(3) Weekly 
(4) Daily or almost daily 
 
Record total of specific items here  
If total is greater than recommended cut-off, consult User’s Manual. 
 
 
 
 
 
 
 
The Alcohol Use Disorders Identification Test: Self-Report Version 
 
 
PATIENT: Because alcohol use can affect your health and can interfere with certain medications and 
treatments, it is important that we ask some questions about your use of alcohol. Your answers will 
remain confidential so please be honest. Place an X in one box that best describes your answer to 
each question. 
 
Questions 0 1 2 3 4  
        
1. How often do you have Never Monthly 2-4 times 2-3 times 4 or more  
 a drink containing alcohol?  or less a month a week times a week  
        
2. How many drinks containing 1 or 2 3 or 4 5 or 6 7 to 9 10 or more  
 alcohol do you have on a typical       
 day when you are drinking?       
    
3. How often do you have six or Never Less than Monthly Weekly Daily or  
 more drinks on one  monthly   almost  
 occasion?     daily  
        
4. How often during the last Never Less than Monthly Weekly Daily or  
 year have you found that you  monthly   almost  
 were not able to stop drinking     daily  
 once you had started?       
        
5. How often during the last Never Less than Monthly Weekly Daily or  
 year have you failed to do  monthly   almost  
 what was normally expected of     daily  
 you because of drinking?       
        
6. How often during the last year Never Less than Monthly Weekly Daily or  
 have you needed a first drink  monthly   almost  
 in the morning to get yourself     daily  
 going after a heavy drinking       
 session?       
    
7. How often during the last year Never Less than Monthly Weekly Daily or  
 have you had a feeling of guilt  monthly   almost  
 or remorse after drinking?     daily  
        
8. How often during the last year Never Less than Monthly Weekly Daily or  
 have you been unable to remem-  monthly   almost  
 ber what happened the night     daily  
 before because of your drinking?       
        
9. Have you or someone else No  Yes, but  Yes,  
 been injured because of   not in the  during the  
 your drinking?   last year  last year  
       
10. Has a relative, friend, doctor, or No  Yes, but  Yes,  
 other health care worker been   not in the  during the  
 concerned about your drinking   last year  last year  
 or suggested you cut down?       
        
      Total  
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Hamilton Depression Rating Scale (HDRS)  
 
 
Reference: Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;  
23:56–62 
 
 
Rating Clinician-rated range (or in clinical remission), while a score of 20 or
Administration time 20–30 minutes 
higher (indicating at least moderate severity) is usually
required for entry into a clinical trial.   
Main purpose To assess severity of, and 
change in, depressive symptoms 
 
Population Adults 
 
 
Commentary 
 
The HDRS (also known as the Ham-D) is the most wide-ly 
used clinician-administered depression assessment scale. 
The original version contains 17 items (HDRS17) pertain-
ing to symptoms of depression experienced over the past 
week. Although the scale was designed for completion 
after an unstructured clinical interview, there are now 
semi-structured interview guides available. The HDRS was 
originally developed for hospital inpatients, thus the 
emphasis on melancholic and physical symptoms of 
depression. A later 21-item version (HDRS21) included 4 
items intended to subtype the depression, but which are 
sometimes, incorrectly, used to rate severity. A limitation 
of the HDRS is that atypical symptoms of depression (e.g., 
hypersomnia, hyperphagia) are not assessed (see SIGH-
SAD, page 55). 
 
 
Versions 
 
The scale has been translated into a number of 
languages including French, German, Italian, Thai, and 
Turkish. As well, there is an Interactive Voice Response 
version (IVR), a Seasonal Affective Disorder version 
(SIGH-SAD, see page 55), and a Structured Interview 
Version (HDS-SIV). Numerous versions with varying 
lengths include the HDRS17, HDRS21, HDRS29, 
HDRS8, HDRS6, HDRS24, and HDRS7 (see page 30). 
 
 
Additional references 
 
Hamilton M. Development of a rating scale for 
primary depressive illness. Br J Soc Clin Psychol 
1967; 6(4):278–96. 
 
Williams JB. A structured interview guide for the 
Hamilton Depression Rating Scale. Arch Gen 
Psychiatry 1988; 45(8):742–7. 
 
 
Scoring 
 
Address for correspondence 
 
Method for scoring varies by version. For the HDRS17, a 
score of 0–7 is generally accepted to be within the normal 
 
The HDRS is in the public domain.  
 
 
 
Hamilton Depression Rating Scale (HDRS) 
 
 
PLEASE COMPLETE THE SCALE BASED ON A STRUCTURED INTERVIEW  
Instructions: for each item select the one “cue” which best characterizes the patient. Be sure to record the answers in the 
appropriate spaces (positions 0 through 4).  
 
1 DEPRESSED MOOD (sadness, hopeless, helpless, worthless)  
0 |__| Absent. 
1 |__| These feeling states indicated only on questioning.
2 |__| These feeling states spontaneously reported verbally.
3 |__| Communicates feeling states non-verbally, i.e. through
  facial expression, posture, voice and tendency to weep.
4 |__| Patient reports virtually only these feeling states in
  his/her spontaneous verbal and non-verbal 
  communication. 
 
2 FEELINGS OF GUILT  
0 |__| Absent. 
1 |__| Self reproach, feels he/she has let people down.
2 |__| Ideas of guilt or rumination over past errors or sinful
  deeds. 
3 |__| Present illness is a punishment. Delusions of guilt.
4 |__| Hears accusatory or denunciatory voices and/or 
  experiences threatening visual hallucinations. 
 
3 SUICIDE 
 0 |__| Absent. 
 1 |__| Feels life is not worth living. 
 2 |__| Wishes he/she were dead or any thoughts of possible
   death to self. 
 3 |__| Ideas or gestures of suicide. 
 4 |__| Attempts at suicide (any serious attempt rate 4). 
4   INSOMNIA: EARLY IN THE NIGHT 
 0 |__| No difficulty falling asleep. 
 1 |__| Complains of occasional difficulty falling asleep, i.e.
   more than 1⁄2  hour. 
 2 |__| Complains of nightly difficulty falling asleep. 
5   INSOMNIA: MIDDLE OF THE NIGHT 
 0 |__| No difficulty. 
 1 |__| Patient complains of being restless and disturbed 
   during the night. 
 2 |__| Waking during the night – any getting out of bed rates
   2 (except for purposes of voiding). 
6   INSOMNIA: EARLY HOURS OF THE MORNING 
 0 |__| No difficulty. 
 1 |__| Waking in early hours of the morning but goes back
   to sleep. 
 2 |__| Unable to fall asleep again if he/she gets out of bed.
7 WORK AND ACTIVITIES 
 0 |__| No difficulty. 
 1 |__| Thoughts and feelings of incapacity, fatigue or 
   weakness related to activities, work or hobbies. 
 2 |__| Loss of interest in activity, hobbies or work – either
   directly reported by the patient or indirect in 
   listlessness, indecision and vacillation (feels he/she has
   to push self to work or activities). 
 3 |__| Decrease in actual time spent in activities or decrease
   in productivity. Rate 3 if the patient does not spend at
   least three hours a day in activities (job or hobbies)
   excluding routine chores. 
 4 |__| Stopped working because of present illness. Rate 4 if
   patient engages in no activities except routine chores,
   or if patient fails to perform routine chores unassisted.
 
8 RETARDATION (slowness of thought and speech, 
impaired ability to concentrate, decreased motor activity) 
 
11 ANXIETY SOMATIC (physiological concomitants of 
anxiety) such as: 
gastro-intestinal – dry mouth, wind, indigestion, 
diarrhea, cramps, belching  
cardio-vascular – palpitations, headaches 
respiratory – hyperventilation, sighing 
urinary frequency 
sweating  
0 |__| Absent. 
1 |__| Mild. 
2 |__| Moderate. 
3 |__| Severe. 
4 |__| Incapacitating.
 
12 SOMATIC SYMPTOMS GASTRO-INTESTINAL  
0 |__| None. 
1 |__| Loss of appetite but eating without staff 
  encouragement. Heavy feelings in abdomen.
2 |__| Difficulty eating without staff urging. Requests or
  requires laxatives or medication for bowels or
  medication for gastro-intestinal symptoms. 
 
13 GENERAL SOMATIC SYMPTOMS  
0 |__| None. 
1 |__| Heaviness in limbs, back or head. Backaches,
  headaches, muscle aches. Loss of energy and
  fatigability. 
2 |__| Any clear-cut symptom rates 2. 
 
14 GENITAL SYMPTOMS (symptoms such as loss of 
libido, menstrual disturbances) 
0 |__| Absent.
1 |__| Mild. 
2 |__| Severe.
 
15 HYPOCHONDRIASIS  
0 |__|   Not present.  
1 |__|   Self-absorption (bodily).  
2 |__| Preoccupation with health. 
3 |__| Frequent complaints, requests for help, etc.
4 |__| Hypochondriacal delusions. 
 
16 LOSS OF WEIGHT (RATE EITHER a OR b)  
a) According to the b) According to weekly  
patient: measurements: 
0 |__| Normal speech and thought. 
1 |__| Slight retardation during the interview.
2 |__| Obvious retardation during the interview.
3 |__|   Interview difficult.  
4 |__|   Complete stupor. 
 
9 AGITATION  
0 |__| None. 
1 |__| Fidgetiness. 
2 |__| Playing with hands, hair, etc. 
0 |__| No weight loss. 
 
1 |__| Probable weight loss 
associated with present 
illness. 
2 |__| Definite (according 
to patient) weight loss. 
3 |__| Not assessed. 
0 |__| Less than 1 lb weight loss 
in week.  
1 |__| Greater than 1 lb weight 
loss in week. 
 
2 |__| Greater than 2 lb weight 
loss in week. 
 
3 |__| Not assessed. 
3 |__| Moving about, can’t sit still. 
4 |__| Hand wringing, nail biting, hair-pulling, biting of lips.
 
10 ANXIETY PSYCHIC  
0 |__| No difficulty. 
1 |__| Subjective tension and irritability. 
2 |__| Worrying about minor matters. 
3 |__| Apprehensive attitude apparent in face or speech.
4 |__| Fears expressed without questioning. 
17 INSIGHT  
0 |__| Acknowledges being depressed and ill. 
1 |__| Acknowledges illness but attributes cause to bad food,
  climate, overwork, virus, need for rest, etc. 
2 |__| Denies being ill at all. 
Total score: |__|__| 
 
 
 
 
Modified Kuppuswamy Socioeconomic scale updated for January 2018. 
 
(a) Occupation of the Head of the Family: - 
 
Sr. No. Occupation of the Head Score
   
1 Legislators, Senior Officials & Managers 10 
2 Professionals 9 
3 Technicians and Associate Professionals 8 
4 Clerks 7 
5 Skilled Workers and Shop & Market Sales 6 
 Workers  
   
6 Skilled Agricultural & Fishery Workers 5 
7 Craft & Related Trade Workers 4 
8 Plant & Machine Operators and Assemblers 3 
9 Elementary Occupation 2 
10 Unemployed 1 
(b)Education of the Head of the Family: -  
 
Sr. No. Education of the Head Score 
1 Profession or Honours 7 
2 Graduate 6 
3 Intermediate or diploma 5 
4 High school certificate 4 
5 Middle school certificate 3 
6 Primary school certificate 2 
7 Illiterate 1 
 
(c)Total Monthly Income of the Family: - 
 
Sr. 
No. Updated Updated 
Updated 
Monthly Score
 
Monthly 
Family 
Monthly 
Family 
Family Income 
in  
 Income in Rs. Income in Rs. Rs. (2018)  
 (2012) (2016)   
1 >30375 ≥ 40,430 >126,360 12 
2 15188-30374 
20,210 40,42
9 63,182-126,356 10 
3 11362-15187 
15,160 20,20
9 47,266-63178 6 
4 7594-11361 
10,110 15,15
9 31,591-47262 4 
5 4556-7593 6060 10,109 18,953-31589 3 
6 1521-4555 2021 6059 6327-18949 2 
7 ≤1520 ≤ 2020 ≤6323 1 
 
(d)Kuppuswamy's Socio-Economic Status Scale 2018: - 
 
Sr. No. Score Socioeconomic Class
1 26 29 Upper (I) 
2 16 25 Upper Middle (II) 
3 11 15 Lower Middle (III) 
4 5 10 Upper Lower (IV) 
5 < 5 Lower (V) 
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1 24 1 3 2 1 2 2 1 1 22yr 2yr 2 0 n n n Y n n n na n 1 2 2 1 1 y n
2 36 1 5 6 2 1 3 1 1 24 12 2 0 n Y n n n n n na n 2 0 0 1 1 y n
3 40 2 1 1 1 1 1 1 1 36 4 2 0 n n n n n n n n n 0 0 0 1 2 y n
4 37 1 1 5 2 1 2 1 1 29 8 5 2 n n n n n n n na n 2 0 0 2 2 y y
5 50 2 2 1 1 1 2 1 1 25 25 4 1 n n n y n y n n n 0 0 0 1 1 y n
6 45 2 4 1 1 1 3 1 3 39 8 6 1 y n n n n n y n n 0 0 0 1 1 y n
7 37 2 1 1 1 1 2 1 2 25 8 4 0 n n y y n n n n n 0 0 0 1 2 y y
8 30 1 2 2 1 2 2 1 1 22 8 2 0 n n n y n n n na n 2 2 2 1 1 y n
9 34 1 3 5 2 1 2 1 1 20 14 3 1 n n y n n n n na n 2 0 0 1 1 y y
10 50 2 2 1 1 1 3 1 1 25 25 4 3 n n n y n n y na n 0 0 0 1 2 y n
11 39 2 3 4 2 1 3 1 1 28 10 0 0 n n n n n n y n n 0 0 0 1 1 y n
12 22 1 4 1 1 2 4 1 1 17 5 4 1 n n n n n n n na n 0 0 0 1 2 y n
13 44 2 4 1 1 3 2 1 1 17 20 6 3 n y n n n n n n y 0 0 0 1 1 y y
14 35 2 1 1 1 1 2 2 3 20 15 5 0 y n n n y n y y n 0 0 0 1 1 y n
15 30 2 3 1 1 1 2 1 1 18 12 4 2 y n y n n n y n n 0 0 0 1 1 y n
16 40 2 3 1 1 1 4 3 2 20 20 6 3 y n n n n n y y y 0 0 0 1 2 y y
17 38 2 3 3 2 1 3 1 2 28 10 2 0 n n n y n y n n N 0 0 0 1 2 Y N
18 19 1 5 1 1 2 4 1 1 16 3 2 1 n n n y n n n na n 0 0 0 1 1 Y N
19 29 2 4 1 1 2 2 1 2 18 11 4 2 Y N Y N N N N N N 0 0 0 1 2 y y
20 30 1 3 5 2 2 3 1 28 2 2 0 N N N Y N N N na N 2 2 0 1 2 y n
21 35 1 3 5 2 1 2 3 2 30 5 3 1 Y N Y Y N N N na Y 2 2 0 1 1 y n
22 40 1 3 1 0 1 1 1 2 26 14 6 3 N N N Y Y Y N na N 2 2 0 1 1 y y
23 29 1 4 5 2 2 2 3 1 27 2 2 0 N N N Y N N N na N 1 2 2 1 2 y n
24 25 2 6 1 0 2 2 1 1 23 2 2 0 Y N N N N N N n N 0 0 0 1 1 y n
25 36 1 2 1 0 1 1 1 1 25 11 6 3 N N Y Y N N N na Y 2 2 0 1 1 y y
26 32 1 3 5 2 1 2 2 3 27 5 3 1 N N N Y N N N na N 0 2 0 1 1 y n
27 33 1 2 4 2 2 2 1 1 25 8 4 1 N N Y N N N Y N N 1 2 0 2 1 y n
28 20 2 4 1 0 2 1 1 1 18 2 2 0 N Y N N N N Y N N 0 0 0 1 2 y n
29 36 1 3 1 1 1 2 1 2 25 11 5 3 y n n y n n n na n 0 2 2 1 1 y y
30 38 1 4 3 1 1 2 3 2 28 10 3 1 n n y y n n n na n 2 2 0 1 1 y y
31 41 2 4 1 1 1 2 1 1 20 21 4 2 y n y y n y y n n 0 0 0 2 2 y n
32 24 1 3 2 2 2 2 2 3 20 4 3 2 n n y y n n n na n 2 2 2 1 2 y n
33 29 1 4 5 1 2 2 1 2 26 3 2 0 n n n y n n n na n 2 2 0 1 2 y y
34 28 2 3 1 1 1 3 1 1 27 1 2 0 y n n n n n y n n 0 0 0 1 1 y n
35 27 1 5 5 2 2 3 3 2 22 7 3 1 n n y y n n n na n 2 2 2 1 2 y y
36 20 2 4 1 1 2 3 1 1 19 1 2 1 y n y y n n n n n 0 0 0 1 1 y n
37 45 1 3 5 2 1 3 1 2 30 15 5 3 y n y y n y n na y 2 2 0 1 1 y y
38 29 1 6 5 2 2 3 1 1 26 2 2 0 n n n y n n n na n 1 2 2 1 2 y y
39 32 1 3 2 1 2 2 1 1 27 5 2 2 y n n y n n n na n 2 2 0 1 2 y y
40 40 1 3 3 1 1 1 1 1 27 13 7 3 y n y y n y n na y 2 2 0 1 1 y n
41 30 1 5 5 2 1 2 2 2 29 1 2 0 n n n y n n n na n 2 2 0 1 1 y n
42 44 1 5 4 2 1 2 3 1 30 14 3 0 y n n y y y n na n 1 2 0 2 2 y y
43 31 2 3 1 1 1 2 1 1 28 3 2 0 n n n y n n y n n 0 0 0 1 1 y n
44 33 1 5 4 2 1 2 1 1 30 3 3 1 n n y y n n n na n 2 2 0 1 1 y y
45 30 2 3 1 1 1 2 1 1 18 12 4 2 y n y n n n y n n 0 0 0 1 1 y n
46 38 2 3 3 2 1 3 1 2 28 10 2 0 n n n y n y n NA N 0 0 0 1 2 Y N
47 38 1 4 3 1 1 2 3 2 28 10 3 1 n n y y n n n na n 2 2 0 1 1 y y
48 29 1 4 5 2 2 2 3 1 27 2 2 0 N N N Y N N N na N 1 2 2 1 2 y y
49 35 2 1 1 1 1 2 2 3 20 15 5 0 y n n n y n y y n 0 0 0 1 1 y n
50 39 2 3 4 2 1 3 1 1 28 10 0 0 n n n n n n y n n 0 0 0 1 1 y n
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FO
R
G
E
T
F
U
L
N
E
S
S
r
e
d
u
c
e
d
 
a
t
t
e
n
t
i
o
n
c
o
n
c
e
n
t
r
a
t
i
o
n
 
d
i
f
f
i
c
u
l
t
I
D
E
A
S
 
O
F
 
H
E
L
P
L
E
S
S
h
o
p
e
l
e
s
s
w
o
r
t
h
l
e
s
s
l
o
w
s
e
l
f
e
s
t
t
e
m
P
M
A
-
A
G
I
T
A
T
E
D
P
M
A
-
R
E
T
A
R
D
E
D
C
A
T
A
T
O
N
I
A
s
u
i
c
.
i
d
e
a
s
u
i
c
.
a
t
t
e
D
S
H
A
N
H
E
D
O
N
I
A
D
I
S
S
O
C
I
A
T
I
V
E
A
N
X
I
E
T
Y
P
S
Y
C
H
O
S
I
D
E
L
U
S
I
O
N
H
A
L
L
U
C
I
N
A
T
I
O
N
S
C
A
L
E
S
 
H
A
M
-
D
B
P
R
S
A
U
D
I
T
F
A
G
E
R
S
T
R
O
M
Y Y Y n n n n n y n n Y y N N n y n 22 25 23 8
n Y Y Y y Y n n y n Y Y n n n n Y y 19 30 25 na
y y y n n n n n y n n n n y n n y y 17 27 na na
y n n y n n y n y n n n n y n n n n 15 na 25 na
y y y y n n y n y n n n y y n n n n 16 na na na
n y n y y y y n y n y n n n n n n n 18 na na na
y n y y y y n n y n y n n y n n n n 15 na na na
y y y n y y y n y n y y y y n n y n 23 31 28 6
y y y y y n y y n n y y y y n n y y 20 22 24 na
y y y y y n n n y n y y n y n n n n 18 na na na
y y y y y n n y n n n n n y n n n n 12 na na na
y n n y y y n y n n y n n n n n n n 11 na na na
y y y y y y n n y n y n n y n n n n 20 na na na
y y y y y n n y n n y n y y n n n y 12 15 na na
y y y y y n y y n n n y y n n n y y 21 23 na na
y y y n y y y n y n y y n y n n y y 22 14 na na
y y y y y N N Y N N y N y N N N y y 10 18 na na
N N y N N N y y N N y y-1 y y N N y y 23 29 NA NA
Y Y Y Y N N N Y N N Y Y Y Y N Y Y Y 22 30 na na
Y Y Y Y Y N Y N Y N N N Y Y N N N Y 15 27 22 4
Y Y Y Y N N N Y N N Y N Y Y N N Y N 20 22 12 7
Y Y Y Y N N Y N Y N Y N Y N N N N N 17 na 20 7
Y Y Y Y Y N N Y N N N N N Y N N Y Y 18 27 8 8
Y Y Y Y Y Y Y N Y N Y N N Y N N N N 22 na na na
Y Y Y Y Y Y N Y N N Y Y Y Y N N Y Y 22 29 25 8
Y Y Y Y N N Y N Y N N N N Y N N Y Y 16 31 8
Y Y Y Y N N N N N N N N Y Y N N N N 13 na 9 7
Y Y Y Y N N Y N N N N N N Y N N Y Y 12 32 na na
y y y y y y y y n n y y y y n y y y 20 36 na 10
y y y y y y y y n n y y y y n n y y 16 40 27 9
y y y y y n y n y n y n n y n n n n 18 na na na
n y y y y y y y n n y y y y n y y y 16 37 25 9
n y y y y n y y n n y n y y n n n n 15 na 28 10
n y y y y n y n y n y n n y n n n n 19 na na na
n y y y y y y y n n y y y y n y y y 20 39 26 10
n y y y y n y y n n y n y y n n n n 21 na na na
y y y y y y y y n n y y y y n n y y 16 32 25 9
n y y y y y y y n n y n y y n n y y 15 28 10 8
n y y y y y y n y n y n y y n n y y 15 39 23 11
y y y y y y y y n n y y y y n n y y 21 40 26 12
n y y y y y y n y n n n y y n n n n 15 na 23 7
y y y y y y y n y n y n y y n y y y 17 38 9 8
n y y y y y y n y n y y y y n n n n 16 na na na
n y y y y y y n y n y n y y n n n n 14 na 26 9
y y y y n n n y n n n y y n n n y y 17 36 na na
y y y y y N N Y N N y N y N N N y y 16 38 na na
y y y y y y y y n n y y y y n n y y 16 40 27 9
Y Y Y Y Y N N Y N N N N N Y N N Y Y 18 27 8 8
y n n n n n n y n n y n y n n n n y 13 29 na na
y y y n n n n y n n n n n n n n n n 12 24 na na
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1 42 2 1 1 1 1 2 2 1 20 20 10 6 y N N y N N y N N 0 0 0
2 40 2 1 1 1 1 3 1 1 35 5 2 0 N N N N N N N N N 0 0 0
3 38 2 3 1 1 1 3 1 1 25 13 4 0 y N N N N N y N N 0 0 0
4 50 2 2 1 1 1 2 1 1 40 10 3 0 N N N N N N y N N 0 0 0
5 50 2 1 1 1 1 4 1 1 30 20 10 0 N N N N y y N N N 0 0 0
6 35 2 1 1 1 1 2 1 1 30 5 2 1 N N N N N N N N N 0 1 0
7 47 1 3 5 2 1 2 1 1 43 5 2 0 N N y N N y N NA N 0 0 0
8 46 2 1 1 1 1 3 2 3 46 5month 2 0 N N N N N N N N N 0 0 0
9 50 2 3 1 1 1 2 1 1 45 4 2 0 N N N N N N y N N 0 0 0
10 26 2 6 8 3 2 4 3 1 18 8 3 0 N N N y N N y N N 0 0 0
11 29 1 6 8 3 2 4 1 1 24 5 2 0 N N N N N N N NA N 1 0 0
12 40 1 3 5 2 1 2 1 1 34 6 3 1 N y N N y N N NA N 0 2 0
13 20 2 4 7 2 2 4 1 1 20 3month 1 0 N N y N N N N N N 0 0 0
14 30 2 4 1 1 1 3 1 1 28 2 2 0 n n n n n n Y N N 0 0 0
15 45 2 3 1 1 1 3 1 3 35 10 3 0 N N N N N Y Y N N 0 0 0
16 36 1 3 5 2 2 2 1 1 30 6 2 1 N N N Y N N N NA N 2 0 0
17 28 1 6 8 3 2 4 1 2 28 2MONTHS 1 0 N N Y N N N N NA N 1 0 0
18 46 1 3 4 1 1 2 1 1 46 3MONTHS 1 0 N Y N N Y Y N NA N 0 0 0
19 38 1 4 5 2 1 2 1 2 35 3 3 1 N N N Y N Y N NA N 0 2 0
20 47 1 6 7 3 1 3 1 2 40 7 2 0 N N N N Y Y N NA N 1 2 0
21 35 1 5 5 2 3 1 1 1 30 5 2 0 N N N Y N N N NA N 1 0 0
22 41 1 3 4 2 1 2 1 1 41 2MONTHS 1 0 N N Y N N N N NA N 2 2 0
23 43 1 3 2 1 1 1 1 1 35 8 3 2 Y N N Y N Y N NA N 1 2 0
24 24 1 4 5 1 2 3 3 1 24 1MONTH 1 0 N N N N N N N NA N 0 2 0
25 38 1 2 5 2 1 2 1 1 30 8 3 1 N N N Y Y Y N NA N 2 2 0
26 30 2 3 1 1 1 2 1 1 28 2 2 1 y n n n n n y NA n 0 0 0
27 35 2 4 2 2 1 2 1 2 30 5 3 1 Y N Y Y N Y Y N N 0 0 0
28 40 2 4 2 2 1 2 1 1 35 5 2 0 Y N N N N Y Y N N 0 0 0
29 45 2 1 1 1 1 1 1 3 35 10 3 1 N N Y Y Y Y Y N N 0 0 0
30 30 2 4 2 1 1 2 1 1 25 5 2 1 Y Y Y Y N N Y N N 0 0 0
31 25 2 5 3 2 2 3 1 1 25 3MONTH 1 1 Y N N Y N N Y Y N 0 0 0
32 20 2 6 1 1 2 3 1 1 18 2 2 1 Y N N Y N N N N N 0 0 0
33 35 2 1 1 1 1 2 1 1 30 5 2 1 N N N N N N N N n 0 1 0
34 50 2 1 1 1 1 4 1 1 30 20 10 0 N N N N y y N N n 0 0 0
35 42 2 1 1 1 1 2 2 1 20 20 10 6 y N N y N N y N n 0 0 0
36 40 2 1 1 1 1 3 1 1 35 5 2 0 N N N N N N N N n 0 0 0
37 38 2 3 1 1 1 3 1 1 25 13 4 0 y N N N N N y N n 0 0 0
38 50 2 2 1 1 1 2 1 1 40 10 3 0 N N N N N N y N n 0 0 0
39 46 2 1 1 1 1 3 2 3 46 5month 2 0 N N N N N N N N n 0 0 0
40 50 2 3 1 1 1 2 1 1 45 4 2 0 N N N N N N y N n 0 0 0
41 26 2 6 8 3 2 4 3 1 18 8 3 0 N N N y N N y N n 0 0 0
42 47 1 3 5 2 1 2 1 1 43 5 2 0 N N y N N y N NA n 0 0 0
43 36 2 3 2 2 1 1 1 2 34 2 2 1 N N N Y N Y Y N N 0 0 0
44 31 2 4 4 2 2 2 1 1 30 1 2 0 N N N Y N N Y N N 0 0 0
45 40 2 4 2 2 1 2 1 1 35 5 2 0 Y N N N N Y Y N N 0 0 0
46 45 2 1 1 1 1 1 1 3 35 10 3 1 N N Y Y Y Y Y N N 0 0 0
47 43 1 3 2 1 1 1 1 1 35 8 3 2 Y N N Y N Y N NA N 1 2 0
48 33 2 2 1 1 1 2 1 2 30 3 2 0 Y N N Y N N Y N N 0 0 0
49 36 2 1 1 1 1 1 1 3 33 3 2 0 N N N Y N Y N N N 0 0 0
50 30 2 4 2 1 1 2 1 1 25 5 2 1 Y Y Y Y N N Y N N 0 0 0
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1 1 n n N y y y y N N N y N y N y N N N N N 15 NA NA NA
1 1 n n N y y y y N y N y N y y y y N N N N 15 NA NA NA
1 1 n n y y y y y y N N y N y N N y N N y N 10 12 NA NA
1 1 n n N N y y y N N N y N y N N y N N N N 15 NA NA NA
1 1 n n y y y y N N N N N N N N N y N N N N 14 NA NA NA
1 1 n n y N N y N N N N y N y N N y N N N N 9 NA NA 7
1 1 y n N y y y N N N N N N y N N N N N N N 16 NA NA NA
1 1 n y y y y y y N y N y N N N N N N N N N 18 NA NA NA
1 1 n n y y y y y N N N y N N N N y N N N N 14 NA NA NA
1 1 n n N y y y N N N N y N Y N N y N N N N 13 NA NA NA
1 1 n n y N y y y N y N y N N N N y N N N N 14 NA 8 NA
1 1 n n y y y N y y y N y N N N y N N N Y N 16 14 NA 7
1 1 n n N N y y y N N N y N y y y y N N N N 19 NA NA NA
1 1 n y Y Y Y Y Y Y Y N Y N Y Y Y Y N N N N 20 NA NA NA
1 1 n y Y Y Y Y Y N Y N Y N Y Y N Y N N Y N 22 27 NA NA
1 1 n n Y Y Y Y Y Y Y N Y N Y Y Y N Y N Y Y 18 20 22 NA
1 1 n n Y Y Y Y Y Y N N Y N Y Y N Y N N N N 20 NA 11 NA
1 1 n n Y Y Y Y Y N Y N Y N Y N N Y N N N N 18 NA NA NA
1 1 n n Y Y Y Y N N Y N Y N Y N Y Y N N N N 17 NA NA 8
1 1 n n Y Y Y Y N N N Y N Y N N N Y N N N N 15 NA 6 6
1 1 n n Y Y Y Y N N Y N Y N N N N Y N N N N 11 6 NA NA
1 1 n n Y Y Y Y Y Y Y N Y N Y Y Y Y N N N N 22 NA 24 9
1 1 n n Y Y Y Y Y Y Y N Y N Y Y N Y N N N N 22 NA 11 11
1 1 n n Y Y Y Y N N Y N Y N Y N N Y N N N N 50 NA NA 10
1 1 n n Y Y Y Y Y Y Y N Y N Y Y N Y N N N Y 22 20 21 9
1 1 n y n y y y n n y n y n y n n y n n n n 15 NA NA NA
1 1 N Y N Y Y Y Y Y Y N Y N Y Y N Y N N Y Y 20 37 NA NA
1 1 Y Y N Y Y Y Y N N N Y N N N N Y N N N N 18 NA NA NA
1 1 N N Y Y Y Y N N N Y Y N Y N N Y N N N N 15 NA NA NA
1 1 Y Y N Y Y Y Y Y Y N Y N Y Y N Y N N N Y 22 34 NA NA
1 1 Y N N Y Y Y Y Y Y N Y N Y N N Y N N N N 19 NA NA NA
1 1 Y N N Y Y Y Y Y Y N Y N Y Y N Y N N N N 17 NA NA NA
1 1 n n y N N y N N N N y N y N N y N N N N 15 NA NA NA
1 1 n n y y y y N N N N N N N N N y N N N N 16 NA NA NA
1 1 n n N y y y y N N N y N y N y N N N N N 20 NA NA NA
1 1 n n N y y y y N y N y N y y y y N N N N 13 NA NA NA
1 1 n n y y y y y y N N y N y N N y N N y N 14 NA NA NA
1 1 y y N N y y y N N N y N y N N y N N N N 17 NA NA NA
1 1 n n y y y y y N y N y N N N N N N N N N 19 NA NA NA
1 1 n n y y y y y N N N y N N N N y N N N N 15 NA NA NA
1 1 n n N y y y N N N N y N Y N N y N N N N 17 NA NA NA
1 1 y n N y y y N N N N N N y N N N N N N N 19 NA NA NA
1 1 N N N Y Y Y Y Y N N Y N Y N N Y N N N N 16 NA NA NA
1 1 N N N Y Y Y Y Y N N Y N N N N Y N N N N 14 NA NA NA
1 1 Y Y N Y Y Y Y N N N Y N N N N Y N N N N 18 NA NA NA
1 1 N N Y Y Y Y N N N Y Y N Y N N Y N N N N 15 NA NA NA
1 1 n n Y Y Y Y Y Y Y N Y N Y Y N Y N N N N 22 NA 11 11
1 1 N N N Y Y Y Y N Y N Y N N N N Y N N N N 13 NA NA NA
1 1 N N N Y Y Y Y N Y N Y N N N N Y N N N N 16 NA NA NA
1 1 Y Y N Y Y Y Y Y Y N Y N Y Y N Y N N N Y 22 34 NA NA
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